Also, we reported that MYB is a top-ranked TF in pan-cancer and prostate cancer, which is also verified by the work of Yan et al. [13] that lists MYB as one of the most frequently appeared TFs in FFLs across six cancer datasets including prostate cancer. This evidence concerns the gene MYB and prostate cancer.